tirzepatide approved by fda approval for Zepbound: FSU researcher available for context on newly weight loss treatment Tirzepatide, the new FDA approved

17.6 (a, b) Ancient schwannoma of the left upper arm in a 24-year-old male: (a) axial T2-WI shows a heterogeneous mass of intermediate signal intensity and some well-circumscribed zones of high signal intensity

That point matters

These drugs are expensive, insurance coverage is inconsistent, and supply shortages have made them difficult to obtain, even for patients with clear medical needs

For instance, PeptiDream has transferred its technology platform to major pharmaceutical companies, such as Merck, Lilly, Bristol-Myers Squibb, Novartis, Genentech and Astellas, to enhance their drug discovery initiatives

Product and market familiarity: Understanding of digital health products, virtual care models, and cardiometabolic or chronic disease programs